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Aggregation of the high-afﬁnity IgE receptor (FcεRI) initiates a cascade of signaling events
leading to release of preformed inﬂammatory and allergy mediators and de novo synthesis
and secretion of cytokines and other compounds.The ﬁrst biochemically well deﬁned step
of this signaling cascade is tyrosine phosphorylation of the FcεRI subunits by Src family
kinase Lyn, followed by recruitment and activation of spleen tyrosine kinase (Syk). Activity
of Syk is decisive for the formation of multicomponent signaling assemblies, the signalo-
somes, in the vicinity of the receptors. Formation of the signalosomes is dependent on
the presence of transmembrane adaptor proteins (TRAPs). These proteins are character-
ized by a short extracellular domain, a single transmembrane domain, and a cytoplasmic
tail with various motifs serving as anchors for cytoplasmic signaling molecules. In mast
cells ﬁve TRAPs have been identiﬁed [linker for activation of T cells (LAT), non-T cell acti-
vation linker (NTAL), linker for activation of X cells (LAX), phosphoprotein associated with
glycosphingolipid-enriched membrane microdomains (PAG), and growth factor receptor-
bound protein 2 (Grb2)-binding adaptor protein, transmembrane (GAPT)]; engagement of
four of them (LAT, NTAL, LAX, and PAG) in FcεRI signaling has been documented. Here we
discuss recent progress in the understanding of how TRAPs affect FcεRI-mediated mast
cell signaling. The combined data indicate that individual TRAPs have irreplaceable roles in
important signaling events such as calcium response, degranulation, cytokines production,
and chemotaxis.
Keywords: mast cells, IgE receptor, plasma membrane, transmembrane adaptor proteins, LAT/LAT1,
NTAL/Lab/LAT2, LAX, PAG/Cbp
INTRODUCTION
Activation through the high-afﬁnity IgE receptor (FcεRI) and
other immunoreceptors is characterized by formation of multi-
protein signaling assemblies (signalosomes) on the cytoplasmic
side of the plasma membrane. The initial well characterized step in
this process is phosphorylation of the immunoreceptor tyrosine-
based activation motifs (ITAMs) in the cytoplasmic tails of the
FcεRI β and γ subunits by Src family protein tyrosine kinase (PTK)
Lyn (Eiseman and Bolen, 1992; Yamashita et al., 1994). Although
the exact molecular events preceding this activation step are not
completely clear, several models of the action mechanism have
been proposed, including the transphosphorylation model (Pri-
bluda et al., 1994), the lipid raft model (Field et al., 1995), and the
PTK–protein tyrosine phosphatase (PTP) interplay model (Buga-
jev et al., 2010; Heneberg et al., 2010). Tyrosine-phosphorylated
ITAMs of the FcεRI γ subunits serve as docking sites for the tan-
dem Src homology (SH)2 domains of the non-receptor tyrosine
kinase spleen tyrosine kinase (Syk) of the Syk/Zap-70 family. Syk
bound to ITAMs adopts an active conformation, facilitating its
phosphorylation by Lyn and further increase in enzymatic activity.
Consequently, Syk phosphorylates a number of its targets critical
for further propagation of the signal, including transmembrane
adaptor proteins (TRAPs; see below), SH2 domain-containing
leukocyte phosphoprotein of 76 kDa (SLP-76; Bubeck et al., 1996;
Hendricks-Taylor et al., 1997), phospholipase C (PLC)γ (Yablon-
ski et al., 2001), and p85 (Shim et al., 2004). The SLP-76 and
some other signaling molecules are constitutively bound to small
linker molecules growth factor receptor-bound protein 2 (Grb2)
or Grb2-related adaptor downstream of Shc (Gads). These linker
proteins posses two SH3 domains surrounding an SH2 domain.
The SH3 domains serve for constitutive binding to SLP-76 and
other proteins with proline-rich domains, whereas SH2 domains
bind to tyrosine-phosphorylated motifs on the TRAPs.
Transmembrane adaptor proteins serve as plasma membrane
docking sites for cytoplasmic signaling molecules, or as anchors
of cytoskeletal components to the plasma membrane. TRAPs are
characterized by a short extracellular domain, a single transmem-
brane domain, and a cytoplasmic tail, which has no intrinsic enzy-
matic activity but possesses various tyrosine-containing motifs
and domains. Extracellular domains are composed of only few
amino acids and are therefore unlikely to function as receptors
for extracellular ligands. The properties of the transmembrane
domains and the presence or absence of juxtamembrane palmi-
toylation motif, CXXC, determine the solubility of TRAPs in
non-ionic detergents, distribution in the plasma membrane, and
some other functional properties. Individual tyrosine residues in
the cytoplasmic tail of the TRAPs are initially phosphorylated by
PTKs of the Src and/or Syk/Zap-70 families and contribute to the
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function of the TRAPs as molecular scaffolds recruiting the down-
stream effector proteins. Five TRAPs have been identiﬁed in mast
cells: linker for activation of T cells (LAT), non-T cell activation
linker (NTAL), linker for activation of X cells (LAX,X indicates“to
be deﬁned”), phosphoprotein associated with glycosphingolipid-
enriched membrane microdomains (GEMs) (PAG), and Grb2-
binding adaptor protein, transmembrane (GAPT). Several reviews
have been published on structural and functional properties of
TRAPs in immunoreceptor signaling (Horejší et al., 2004; Gilﬁllan
and Tkaczyk, 2006; Simeoni et al., 2008;Alvarez-Errico et al., 2009;
Fuller andZhang,2009;Balagopalan et al., 2010; Fuller et al., 2011).
Here we focus on more recent advances from studies examining
the role of TRAPs in FcεRI signaling.
LINKER FOR ACTIVATION OF T CELLS
This TRAP, also termed LAT1,was initially detected as a prominent
36–38 kDa tyrosine-phosphorylated protein occurring as a conse-
quence of the T cell receptor (TCR) engagement (June et al., 1990).
Later it was cloned (Weber et al., 1998; Zhang et al., 1998a) and
found to be expressed in several cell types, including natural killer
(NK) cells, megakaryocytes, platelets, immature B cells, and mast
cells (Facchetti et al., 1999; Oya et al., 2003). Other studies showed
that LAT could be phosphorylated by Syk or ZAP-70, depending
on the cell type studied, and that phosphorylated LAT associated
directly or indirectly with numerous signaling molecules such as
Grb2,PLCγ1,guaninenucleotide exchange factorVav,Cbl,SLP-76,
and Gads (Gilliland et al., 1992; Buday et al., 1994; Sieh et al., 1994;
Trub et al., 1997; Finco et al., 1998; Zhang et al., 1998a; Liu et al.,
1999; Ishiai et al., 2000). LAT is one of the most important TRAPs
in immunoreceptor signaling. Sequencing of human, mouse, and
rat LAT cDNA revealed an open reading frame encoding, respec-
tively, 233, 242, and 241 amino acid-containing proteins. As other
TRAPs,LATpossesses a very short extracellular region (four amino
acids), a single transmembrane spanning domain, and a long
cytoplasmic region without any intrinsic enzymatic activity, but
containing various motifs (Figure 1). The cytoplasmic domain
possesses nine tyrosine residues conserved in humans, mice, and
rats, of which ﬁve can be phosphorylated and serve as binding sites
for SH2 domain-containing proteins (Paz et al., 2001; Zhu et al.,
2003). There are also two conserved cysteine residues, located in
the vicinity of the transmembrane domain, which are the sub-
ject of post-translational palmitoylation (Zhang et al., 1998b).
Two potential ubiquitylation sites (K52 and K204 in human LAT)
might be involved in the regulation of LAT protein levels and
internalization of LAT complexes (Balagopalan et al., 2011).
In FcεRI-activated mast cells LAT becomes rapidly phosphory-
lated with peak reaching 2min after triggering. In mice deﬁcient
in LAT, the development of mast cells was not affected (Saitoh
et al., 2000), in contrast to development of T cells (Zhang et al.,
1999), but the animals were resistant to IgE-mediated passive sys-
temic anaphylaxis. This suggests that function of mast cells in
LAT−/− mice is compromised. Differentiation of mast cells from
bone marrow precursors under in vitro conditions was unaffected
by the absence of LAT, but activation of the bone marrow-derived
mast cells (BMMCs), manifested as tyrosine phosphorylation
of numerous substrates, mobilization of intracellular calcium,
degranulation, and transcription of several cytokine genes was
markedly impaired. However, inhibition was incomplete, suggest-
ing that some other TRAPs could also be involved (see Figure 2
and below). Antigen-induced early activation events, such as tyro-
sine phosphorylation of the FcεRI β and γ subunits as well as
tyrosine phosphorylation of Syk were not affected by the absence
of LAT, which is in line with ﬁndings that LAT is a substrate for
Syk. In contrast, LAT distal events, like tyrosine phosphorylation
of PLCγ1, PLCγ2, and SLP-76,were markedly inhibited in LAT−/−
BMMCs.
Based on the studieswith LATmutants transfected into LAT−/−
BMMCs, it was concluded that the most important tyrosine
in human and mouse LAT is the Y132 and Y136, respectively
(Figure 1). This tyrosine is found in motif YLVV, which consti-
tutes amajor docking site for PLCγ1;most PLCγ1-dependent steps
are therefore inhibited in mouse cells with LAT mutated at Y136
(Saitoh et al., 2003). The activity of PLCγ1 was also inhibited in
some other mutants deﬁcient in Grb2-binding motifs. This can be
explained by involvement of Grb2 in PLCγ1–LAT interactions.
Further studies showed that combinations of mutants in LAT
tyrosines (ﬁve proximal and four distal) resulted in both decreased
and increased degranulation and cytokines production, depend-
ing on the tyrosine(-s) mutated. These data support the concept
that LAT could regulate FcεRI signaling not only positively, but
also negatively (Malbec et al., 2004). Negative regulation of FcεRI
signaling seems to be mediated by the most distal tyrosine, which
provides a major binding site for SHIP1 (SH2 domain-containing
inositol 5-phosphatase; Roget et al., 2008). SHIP1 acts as potent
inhibitor of mast cell signaling by removing 5-phosphate groups
in the inositol ring of 3-phosphorylated inositides and phos-
phatidylinositides, and thus prevents membrane recruitment of
molecules containing pleckstrin homology domains (Scharenberg
et al., 1998). Furthermore, membrane bound SHIP1 negatively
regulates the Ras pathway by recruitingDok-1 andRasGAP (Tamir
et al., 2000).
Biochemical studies indicated that dually palmitoylated LAT is
localized in plasma membrane microdomains resistant to solubi-
lization by non-ionic detergents (Zhang et al., 1998b). This was
taken as evidence that LAT is a marker of lipid rafts. In contrast,
FcεRI in quiescent cells is detergent soluble, a fact suggesting that
it is localized outside lipid rafts. After aggregation, FcεRI became
detergent insoluble, strengthening thus the concept that antigen-
inducedmast cell signaling is initiatedby amovement of FcεRI into
lipid rafts (as assumed by the lipid raft model mentioned above),
where it is phosphorylated by Lyn kinase considered to be constitu-
tively associated with lipid rafts. However, immunogold electron
microscopy studies on isolated plasma membrane sheets failed
to bring direct evidence supporting the notion that aggregated
FcεRI and LAT are located in the same membrane compart-
ments. In fact, LAT-containing plasma membrane microdomains
and FcεRI-containing domains were separated before activation
and remained separated after activation, even though they were
enlarged in size (Wilson et al., 2002, 2004; Lebduška et al., 2007;
Carroll-Portillo et al., 2010). Molecular basis of this segregation is
unclear, though it could provide a basis for short “kiss-and-run”
interactions of FcεRI-anchored Syk and its substrate, LAT. Such
interactions could be preferable for the transient nature of FcεRI
signaling. Contrary to that, prolonged interaction of Syk and LAT
Frontiers in Immunology | Inﬂammation January 2012 | Volume 2 | Article 95 | 2
Draber et al. TRAPs in FcεRI signaling
FIGURE 1 | Schematic illustration ofTRAPs studied in human and
mouse mast cells. All ﬁveTRAPs are characterized by a short
extracellular domain, a transmembrane domain, and a cytoplasmic
domain with various motifs. LAT, NTAL, and PAG possess
juxtamembrane CxxC palmitoylation site for their interactions with lipids
and localization in detergent-resistant membranes. All TRAPs have
various tyrosine-based motifs which after phosphorylation serve as
binding sites for the indicated SH2-containing proteins. PAG also
contains proline-rich domains serving as anchor for SH3-containing
proteins. Number of amino acids (AA) in eachTRAP as well as accession
numbers in the GenBank sequence database provided by National
Center for Biotechnology Information (NCBI) are also shown.
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FIGURE 2 | FcεRI signaling events inWT, NTAL−/−, and LAT−/− cells. In
WT cells expressing both NTAL and LAT, aggregation of the receptors by
multivalent antigen leads to rapid Lyn kinase-mediated phosphorylation of
tyrosine residues in ITAM motifs of FcεRI β and γ subunits, followed by
anchor of Syk to FcεRI through interaction of Syk SH2 domains with
phosphorylated ITAMs. Syk then phosphorylates NTAL and LAT to create
binding sites for various SH2-containing proteins. Phosphorylated LAT
allows direct binding of SH2 domains of PLCγ1, Grb2, Gads, and SHIP1.
Grb2 and Gads serve as binding sites and stabilizers for other molecules
including SLP-76, VAV, and SOS. Activity of PLCγ1 leads to enhanced
production of IP3 and DAG, followed by increased Ca2+ inﬂux, degranulation,
and production of transcription factors. Phosphorylated NTAL also binds
Grb2 and some other signaling proteins, except for PLCγ1. However, even in
the absence of binding to PLCγ1, NTAL can modulate Ca2+ signaling,
degranulation, and cell survival through indirect cross-talk with PI3 activation
pathway. In activated NTAL−/− cells, an important Syk substrate (NTAL) is
missing and LAT is therefore more phosphorylated. This leads to enhanced
binding and activity of PLCγ1 and all subsequent PLCγ-dependent events.
However, NTAL-dependent activity of Akt is impaired and this could lead to
decreased cell survival. In activated LAT−/− cells, decreased Ca2+ inﬂux,
degranulation, and production of transcription factors are due to the
absence of PLCγ1 anchored to LAT. The remaining weak Ca2+ response,
degranulation and production of transcription factors is based on
NTAL-mediated activation events.
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inmixeddomains containing bothLATandFcεRI (with Syk) could
provide more stable structures (“kiss-and-stick”) which would be
more difﬁcult to regulate by phosphatases and other regulatory
molecules. Similarly, most of Lyn–FcεRI interactions are transient
(Oliver et al., 2000).
NON-T CELL ACTIVATION LINKER
This adaptor protein, also termed linker for activation of B cells
(LAB) or LAT2,was ﬁrst identiﬁed in myeloid cell lines HL-60 and
THP-1 as a 30-kDa phosphorylated protein not detectable in T
cells (Brdicka et al., 2002). In parallel, this TRAP was also discov-
ered by search in human genome database for molecules with ﬁve
Grb2-binding motifs (YXN, where X stands for any amino acid),
putative transmembrane domain with a stretch of hydrophobic
residues and potential palmitoylation sites (Janssen et al., 2003).
NTAL is expressedmainly in B cells,NK cells,monocytes, andmast
cells, but not in quiescent T cells. Although NTAL has structural
features similar to LAT (Figure 1), there is no major homology
in amino acid sequences between these two adaptors. NTAL pos-
sesses 10 tyrosines within the cytosolic tail; ﬁve of them within the
putative Grb2-binding sites and one within the putative SHP1/Src
kinase-binding site (YIDP). In contrast to LAT,NTAL is lacking the
PLCγ1 binding motif. In cells activated through FcεRI, NTAL was
rapidly phosphorylated by Syk and Lyn kinase. Interestingly, these
kinases produced entirely different pattern of phosphorylation of
the individual tyrosines (Iwaki et al., 2008).
Experiments in vivo showed that mice with NTAL knock-out
exhibited signiﬁcantly enhanced passive systematic anaphylaxis;
this implies that NTAL has a negative regulatory role in mast
cells signaling (Volná et al., 2004). This conclusion was conﬁrmed
by in vitro studies comparing the properties of antigen-activated
BMMCs derived from NTAL-deﬁcient or WT mice. NTAL−/−
cells exhibited enhanced phosphorylation of LAT, PLCγ1, PLCγ2,
extracellular signal-regulated kinase (Erk), calcium mobilization,
degranulation, cytokines production, and enzymatic activity of
inositol 1,4,5-trisphosphate (Figure 2, NTAL−/−). Interestingly,
mast cells lacking both LAT and NTAL exhibited a stronger block
in FcεRI signaling than LAT−/− mast cells, demonstrating again
that NTAL could play both positive and negative roles in FcεRI
signaling (Volná et al., 2004; Zhu et al., 2004).
All above mentioned data were obtained in experiments with
mouse-derived mast cells. However, when human mast cells with
decreased NTAL expression were analyzed, impaired degranula-
tion was observed, indicating prevalence of positive regulation
of NTAL in that system (Tkaczyk et al., 2004). The observed
difference between human and mouse mast cells could reﬂect
qualitatively or quantitatively differentmolecular context in which
these molecules operate. Furthermore, there were differences in
methods used for NTAL silencing. Mouse mast cells were obtained
from animals lacking NTAL by genetic knock-out. It is possi-
ble that compensatory mechanisms during mouse development
led to quantitative or qualitative “compensatory” changes in the
expression of some other signaling molecules. On the other hand,
in experiments with human mast cells, NTAL was silenced only
partially (by ∼72%) by exposing the cells to NTAL-speciﬁc small
interfering (si)RNA, and tests were performed 64 h later. In this
case, compensatory mechanisms are unlikely to play any major
role. Although it is not clear what causes the different outcome
of NTAL silencing in mouse and human mast cells, the com-
bined data indicate that NTAL exerts both positive and neg-
ative regulatory roles on FcεRI signaling, and reﬂect thus the
complex nature of regulatory factors involved in this signaling
pathway.
Recent studies by Koretzky and collaborators on mouse
BMMCs deﬁcient in LAT and/or NTAL showed that these two
adaptors bind cytoplasmic adapter molecule SLP-76 via Gads
(Kambayashi et al., 2010). Although NTAL supported SLP-76
phosphorylation and its recruitment to the plasma membrane,
NTAL only partially compensated for LAT-mediated signaling
events. This is attributable to decreased stability of NTAL–
GADS/SLP-76–PLCγ interactions. Since tyrosine phosphoryla-
tion of SLP-76 was not completely lost in LAT and NTAL
double-deﬁcient cells, it suggests that other TRAPs, such as LAX
(see below) could be involved in SLP-76 anchor to the plasma
membrane.
In spite of the similarity in their mode of anchor to the plasma
membrane and poor solubility in non-ionic detergents,NTAL and
LAT occupy different membrane microdomains. This was deter-
mined by immunogold electron microscopy studies on isolated
plasma membrane sheets from non-activated and FcεRI-activated
cells (Figure 3; Volná et al., 2004; Heneberg et al., 2006). The mol-
ecular basis of the observed topographical differences is unknown
but could possibly be related to regulatory mechanisms based on
space separation (see discussion above).
Non-T cell activation linker is also involved in the regula-
tion of cell morphology and cell–substrate interactions. Studies
with rat basophilic leukemia (RBL) cells transfected with NTAL
cDNA showed that the cells expressing more NTAL adhered less
efﬁciently to tissue culture plastic, and exhibited more rounded
shapes and less developed processes than parental RBL cells.
On the contrary, RBL cells with a decreased amount of NTAL
(obtained after transfection of NTAL-speciﬁc hairpin siRNA),
showed fewer but more developed processes. The observed
changes in cellular morphology were apparently caused by dif-
ferences in the function and/or regulation of actin cytoskeleton
network. An indirect support for this conclusion is observa-
tion of an enhanced amount of ﬁlamentous (F)-actin in NTAL-
deﬁcient cells and a decreased amount of F-actin in NTAL
overexpressors (Dráberová et al., 2007). Other studies showed
that FcεRI-activated BMMCs from NTAL-deﬁcient mice, in con-
trast to cells from WT mice, exhibited reduced spreading on
ﬁbronectin (Figure 4), but enhanced F-actin depolymerization
(Tumová et al., 2010). This probably relates to the decrease
in RhoA activity, which is deeper in NTAL−/− cells than WT
cells. Interestingly, spreading on ﬁbronectin after exposure to
stem cell factor (SCF) was similar in WT and NTAL−/− cells
(Figure 4). This indicates that chemotaxis induced by engagement
of FcεRI or c-kit uses, respectively, NTAL-dependent or NTAL-
independent signaling pathways. The important role of NTAL
in FcεRI-induced formation of F-actin assemblies was conﬁrmed
by experiments where defects in both cell spreading and actin
polymerization/depolymerization status in NTAL−/− cells were
restored after transfection of NTAL–GFP construct (Tumová et al.,
2010).
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FIGURE 3 | Non-T cell activation linker, LAT, and FcεRI occupy different
membrane microdomains in non-activated and FcεRI-activated cells.
Plasma membrane sheets were isolated from non-activated (A,C,E) or
antigen-activated (B,D,F) RBL-2H3 cells and double-labeled from the
cytoplasmic side with ﬁrst layer antibodies speciﬁc for the target structures
and second layer anti-antibodies labeled with 5 or 10 nm gold particles. (A,B)
FcεRI β subunit labeled with 10 nm gold (arrows) and NTAL labeled with 5 nm
gold (arrowheads). (C,D) FcεRI β subunit labeled with 10 nm gold (arrows) and
LAT labeled with 5 nm gold (arrowheads). (E,F) LAT labeled with 10 nm gold
(arrows) and NTAL labeled with 5 nm gold (arrowheads). Scale bar in (D),
100 nm. Originally published in Journal of Experimental Medicine (Volná et al.,
2004) where all experimental procedure details have been described.
Non-T cell activation linker is also likely to play a negative regu-
latory role in FcεRI-mediated chemotaxis, since migration toward
antigen was greater in NTAL−/− cells thanWT cells. In accordance
with studies on cell spreading, the absence of NTAL had no dra-
matic effect on migration toward SCF (Tumová et al., 2010). The
combined data suggest that the cross-talk between NTAL and
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FIGURE 4 | Non-T cell activation linker positively regulates spreading
on fibronectin in BMMCs activated via FcεRI but not via SCF.
(A) IgE-sensitized WT cells or NTAL−/− cells were activated for 20min with
antigen or SCF, ﬁxed and stained for F-actin with phalloidin-Alexa Fluor 488
conjugate. The images are confocal micrographs taken at equatorial planes.
Scale bar, 20μm. (B)WT cells (full line) or NTAL−/− cells (dotted line) were
activated with antigen or SCF for the indicated time intervals, ﬁxed and
stained for F-actin as in (A). Proportion of spread cells was calculated from
>200 cells evaluated at each time interval. Means and SE were calculated
from two (5min) or ﬁve (20 and 30min) independent experiments.
Signiﬁcance of differences at given times between WT and NTAL−/− cells is
also shown (*p<0.05; **p<0.005; Student’s t -test). Originally published
in European Journal of Immunology (Tumová et al., 2010) where all
experimental procedure details have been described.
RhoA has a crucial role in the regulation of actin cytoskeleton
dynamics in FcεRI-activated cells.
The exact molecular mechanism of NTAL-dependent signaling
in activated mast cells is not known, and several hypotheses are
conceivable. First, increased phosphorylation of LAT in FcεRI-
activated NTAL−/− cells is accompanied by enhanced binding
of PLCγ1 and PLCγ2 to LAT, followed by increased tyrosine
phosphorylation of these enzymes and, consequently, higher pro-
duction of Ca2+ and degranulation. We have speculated that
enhanced LAT phosphorylation in NTAL−/− cells may be caused
by a decreased competition for Syk between LAT and NTAL
(Volná et al., 2004; Figure 2). Second, it has been demonstrated
that Ca2+ response is higher in NTAL−/− cells than in WT cells
even after stimulation with thapsigargin, an agent that induces
the release of Ca2+ from intracellular stores by inhibiting the
endoplasmic reticulum ATPase (Thastrup et al., 1989). This drug
acts directly on the Ca2+ pump, and LAT and NTAL phos-
phorylation steps are thus bypassed. Noteworthy, dramatically
increased levels of cytoplasmic Ca2+ were observed in experi-
ments with Ca2+-containing media, but not in Ca2+-free media.
This implies that Ca2+ inﬂux plays a major role. Direct analy-
sis of 45Ca inﬂux into the cells has conﬁrmed that NTAL could
regulate the Ca2+ uptake in the absence of its detectable phos-
phorylation. Based on these and other experimental results we
have proposed that NTAL could regulate the activity of Ca2+
channels at the level of plasma membrane by direct or indirect
interactions with Ca2+ channel components (Dráberová et al.,
2007) or that it somehow interacts with store operated Ca2+
entry (SOCE) regulators, such as stromal interaction molecule 1
(STIM1; Dráber and Dráberová, 2005). Third, NTAL could posi-
tively regulate mast cell activation and survival by the recruitment
of SHIP1, and thus decreasing binding of this phosphatase to
LAT (Roget et al., 2008). In this connection it should be men-
tioned that NTAL and LAT also regulate mast cells survival in the
absence of IL-3 by a pathway involving Erk and Ras (Yamasaki
et al., 2007; Roget et al., 2008). In BMMCs derived from mice
deﬁcient in both NTAL and LAT, activation of Erk and Ras was
inhibited, and the survival in the absence of IL-3 was impaired.
Survival of NTAL−/−/LAT−/− cells was restored to WT level
by membrane-targeted Sos, which bypassed the Grb2-mediated
membrane recruitment of Sos. The data suggest that NTAL and
LAT improve cell survival through membrane retention of the
Ras-activating complex Grb2–Sos.
LINKER FOR ACTIVATION OF X CELLS
The LAX adaptor has been discovered when searching the human
genome database for tyrosine motifs found in LAT (Zhu et al.,
2002). Translation of human and mouse LAX cDNA revealed that
LAX gene encodes a putative protein of 398 residues and 407
residues, respectively (Figure 1). Five of the 10 tyrosines in cyto-
plasmic tail of human LAX are within the Grb2-binding motifs.
It also has a Gads motif (YVNV) identical to that in LAT, and
a p85-binding motif (YXXM) which is missing in LAT. In con-
trast to LAT and NTAL, LAX lacks the submembranous CXXC
palmitoylationmotif; this explains its solubility innon-ionic deter-
gents. In activated cells, LAX is tyrosine-phosphorylated by Src
and Syk/Zap-70 family kinases. As shown by transfection studies,
defective signaling in LAT-deﬁcient Jurkat T cells could be rescued
by expression of LAT but not LAX. LAX was also found expressed
in mast cells. Aggregation of the FcεRI in LAX-deﬁcient BMMCs
resulted in enhanced phosphorylation of LAT, activation of p38
MAPK and PI3 kinase, degranulation, cytokines production, and
cell survival. The data suggest that LAX plays an important role in
mast cell function through negative regulation of PI3K pathway.
Although mast cells derived from LAX-deﬁcient mice exhibited
in vitro an enhanced responsiveness after FcεRI triggering, IgE-
dependent systemic anaphylaxis in vivo was comparable between
LAX−/− and WT mice. One explanation for this observation is a
higher basal level of IgE in LAX−/− mice compared to WT mice,
and a competition between exogenous antigen-speciﬁc IgE with
endogenous IgE for surface receptors of target cells (Zhu et al.,
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2006). The expression of NTAL in bothnon-activated and antigen-
activated BMMCs was signiﬁcantly lower in LAX−/− cells than it
was in WT cells. It is therefore possible that at least some of the
observed changes in LAX-deﬁcient cells reﬂect the changed ratio
between LAT and NTAL in favor of LAT. The molecular basis
for the observed decrease of NTAL in LAX-deﬁcient cells remains
hitherto unknown. Better understanding of the problem could
bring experiments comparing properties of WT cells with the cells
in which LAX expression is decreased by siRNAs. Furthermore,
studies based on the whole genome transcriptional analysis from
WT cells and LAX-deﬁcient cells could be informative.
PHOSPHOPROTEIN ASSOCIATED WITH
GLYCOSPHINGOLIPID-ENRICHED MEMBRANE
MICRODOMAINS
This protein, also termed Csk-binding protein (Cbp), was ﬁrst
described in 2000 in two studies analyzing (1) a GEMs-associated
tyrosine-phosphorylated protein of 80 kDa in cell line Raji
(Brdicka et al., 2000) and (2) Csk co-precipitating protein of 80–
90 kDa from neonatal rat brain (Kawabuchi et al., 2000). Like
other TRAPs, PAG has a short extracellular domain (16 amino
acids), a transmembrane domain followed by palmitoylation site,
and a cytoplasmic tail containing 10 tyrosines. Furthermore, it has
two proline-rich sequences which serve as binding sites for SH3
domains. PAG is a substrate for Lck and Fyn but not for Zap-70 or
Syk. PAGphosphorylated on tyrosine 317 (human) or tyrosine 314
(mouse) binds Csk. Based on the initial studies, it was postulated
that Csk binds via its SH2 domain to tyrosine-phosphorylated
PAG. Membrane anchored Csk then phosphorylates C-terminal
tyrosines of Src family kinases in the vicinity of PAG, and inacti-
vates them in this way. In T cells, activation through the TCR leads
to a rapid PAG dephosphorylation, which results in the release of
Csk from the membrane and relief of Csk-mediated inhibition of
Src kinases.
In mast cells, PAG is differently phosphorylated during FcεRI
signaling (Ohtake et al., 2002).Antigen-induced aggregation of the
FcεRI in RBL cells resulted in a rapid increase in tyrosine phos-
phorylation of PAG and its association with Csk. In an attempt to
elucidate the role of PAG in FcεRI-mediated signaling, PAG was
over-expressed in RBL cells and their activation was assessed. As
expected, FcεRI-activated cells with enhanced levels of PAG exhib-
ited decreased tyrosine phosphorylation of FcεRI β andγ subunits,
lower degranulation,and reduced calciumresponse indicating that
PAG is a negative regulator of FcεRI signaling in RBL cells. In vitro
kinase assays showed that over-expression of PAG inhibited the
increase of FcεRI-associated kinase activity induced by antigen
stimulation. These data together with the ﬁnding that tyrosine
phosphorylation of PAG is inhibited by Src-speciﬁc inhibitor PP2
can be taken as evidence that PAG negatively regulates the acti-
vation of FcεRI-bound PTKs, and serves as a negative feedback
regulator for FcεRI signaling.
The described regulatory mechanism was corroborated by
studies of BMMCs cells from epilepsy-prone (EL) and epilepsy-
resistant (ASK) mice (Kitaura et al., 2007). The authors found
that ASK mice exhibited reduced Lyn activity and consequently
reduced tyrosine phosphorylation of Cbp/PAG, combined with
enhanced production of TNF-α and IL-2. The data support the
notion that activation of Lyn leads to enhanced phosphorylation
of PAG, followedby recruitment of Csk toCbp/PAGand inhibition
of Src family kinases localized in the same membrane domains.
GRB2-BINDING ADAPTOR PROTEIN, TRANSMEMBRANE
The GAPT was discovered by in silico screening for novel TRAPs
in human genome database (Liu and Zhang, 2008). This pro-
tein contains seven tyrosine residues in its cytosolic region; four
of them within a Grb2-binding motif (Figure 1). Immunoblot-
ting analysis showed that GAPT is expressed primarily in murine
B220+ spleen cells and total bone marrow cells. It was found less
expressed in dendritic cells and mast cells, and was absent in T
cells and macrophages. When bone marrow cells from WT mice
or mice deﬁcient in GAPT were cultured in the presence of IL-3,
similar numbers of BMMCs were observed after 3 weeks in cul-
ture. Furthermore, aggregation of FcεRI inGAPT+/+ orGAPT−/−
BMMCs resulted in comparable degranulation. These data seem to
indicate that GAPT is not required for BMMCs differentiation and
FcεRI-mediated activation. In contrast to LAT and NTAL,GAPT is
not phosphorylated on tyrosine after FcεRI triggering. However, it
remains to be determined whether GAPT is phosphorylated after
engagement of other receptors. Likewise, the function of GAPT in
migration and other assays has not yet been critically tested.
TRAPs IN OTHER FcεRI-EXPRESSING CELLS
FcεRI is abundantly expressed not only in human and rodent mast
cells, but also in basophils. These two cell types express FcεRI as
a heterotetramer containing one IgE binding subunit α, one β
subunit and two γ subunits (αβγ2). FcεRI is also found in het-
erotrimeric form lacking the β chain (αγ2; Kinet, 1999). These
trimeric forms have been described in human Langerhans’cells
(Bieber et al., 1992; Wang et al., 1992), eosinophils (Gounni et al.,
1994), monocytes (Maurer et al., 1994), peripheral blood den-
dritic cells (Maurer et al., 1996), platelets (Joseph et al., 1997), and
pinealocytes (Ganguly et al., 2007). However, in some cell types
like human eosinophils the FcεRI is not expressed on the plasma
membrane and therefore is not involved in IgE receptor binding
and cell activation (Smith et al., 2000). Interestingly, mice lack
expression of αγ2 form of FcεRI and do not express the recep-
tor on cells other than mast cells and basophils. Information on
the function of TRAPs in FcεRI signaling in cells other than mast
cells is not available and there are only very limited data on the
expression of TRAPs in basophils and other FcεRI-expressing cells
(Ishmael and MacGlashan, 2009).
CONCLUDING REMARKS
Five TRAPs have been characterized in mast cells and four of
them were found to be involved in FcεRI signaling. Apparently
the list is still not complete and other TRAPs will be found. For
example it is not clear whether mast cells express a recently discov-
ered TRAP composed of only 145 amino acids, the SLP65/SLP-76,
Csk interacting membrane protein (SCIMP; Draber et al., 2011).
This protein was detected when searching the databases for TRAP
motifs. In B cells it is tyrosine-phosphorylated after stimulation via
the major histocompatibility complex II. Phosphorylated SCIMP
binds SH2 domains of SLP65/SLP-76 adaptor protein and Csk
and regulates in this way the signal transduction after MHCII trig-
gering. Its role in mast cell development and FcεRI signaling has
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not been determined. Identiﬁcation of all TRAPs and their inter-
action partners involved in mast cell activation is the ﬁrst step
toward understanding the mast cell signaling pathways in their
complexities.
Transmembrane adaptor proteins are equipped for extensive
cross-talk not only with cytoplasmic signaling molecules, but also
with other highly dynamic components of the plasma mem-
brane. How plasma membrane-associated molecules are orga-
nized into functional domains/units in non-activated cells, as
well as their changes in the course of cell activation and partic-
ipation in signalosomes formation is another important set of
problems. For example, the molecular basis of different plasma
membrane topography of two similar TRAPs, namely NTAL and
LAT (see above), remains mysterious and the puzzle suggests
that different signalosomes could be formed in activated cells.
The minimal size of the signalosomes is another unanswered
question. Previous topographical data obtained with cells acti-
vated by FcεRI-dimerizing monoclonal antibody suggested that
the size may be very small (Dráberová et al., 2004) and their
number could be therefore very high. Solution of these prob-
lems will require new methodologies, such as the real-time high-
resolution microscopy on live cells (Fernandez-Suarez and Ting,
2008).
Some of the TRAPs, such as GAPT, with no dramatic effect
on mast cell development and FcεRI signaling, might have their
role(s) masked by compensatory mechanisms. Analysis of mast
cells from animals with multiple gene knock-out or cells with
knock-downs of multiple proteins could thus be very informative.
Also, studies based on conditional knock-out strategy combined
with inducible systems (Sauer, 1998) or using siRNA probes under
in vivo conditions (Shim and Kwon, 2010) could have profound
impact on further understanding of the role TRAPs in mast cell
signaling. In addition, they might provide useful animal models
of mast cell diseases.
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